Radiation dose impacts on size of lung nodules seen on CT images
Research has shown how radiation dose can affect size of lung nodules observed on CT images.
The size of chest lymph nodes and lung nodules identified by CT images depends on the amount of radiation used for the examination.
That is according to new research from the Massachusetts General Hospital in Boston, which found lower radiation doses resulted in a more varied size of lesions seen on CT images.
The team used a 3D image processing tool to quantitatively measure the volume of lymph nodes and lung nodules.
Lymph node volumes were estimated at 30 per cent lower in five cases and ten per cent higher in 25 cases of low dose compared with higher dose images.
The study also found that the calculated volume of lung nodules was 46 per cent lower in nine cases and 34 per cent higher in ten cases on lower dose compared to higher dose images.
Lead author of the study, Dr Beth Vettiyil, said: "We think that increased image noise (graininess of the image) on the lower dose scans may have caused the lesion volumes to vary so significantly."
While the study might suggest radiologists can use these tools to supplement their measurements, Dr Vettiyil added the use of such software measurements without a clinical correlation might not be advisable yet.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance